Phase 2A clinical Trial – CFN Media

TRYP THERAPEUTICS RECEIVES CONFIRMATION FROM FDA TO PROCEED WITH PHASE 2A CLINICAL TRIAL IN PATIENTS WITH IBS AT MASSACHUSETTS GENERAL HOSPITAL

Kelowna Canada, (July 13 2023) — Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF)…

Ryan Allway
July 13, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Consumer Product Stocks

LEEF Brands Inc. Closes Second Tranche Private Placement Financing Round of CAD$500,000

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED…

Ryan Allway
December 20, 2024

LEEF Brands Moves Treasury into Bitcoin, Profits $73k in Weeks

LEEF Brands Inc. (CSE: LEEF) (OTC: LEEEF), a leading cannabis extraction and…

Ryan Allway
December 18, 2024

LEEF Brands to Become One of the First Publicly Traded Cannabis Company to Integrate Bitcoin into its Treasury Reserve via US$5 Million Bitcoin-Backed Debenture Offering

VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) — LEEF Brands, Inc.…

Ryan Allway
December 16, 2024

Consumer Product Stocks

LEEF Brands Inc. Closes Private Placement Financing Round of CAD$2,118,375

VANCOUVER, BC / ACCESSWIRE / December 12, 2024 / LEEF Brands Inc.…

Ryan Allway
December 12, 2024